Dr. Finger Representing All Eye Cancer Specialists At The Commission On Cancer Spring Meeting 2016

Dr. Finger recently attended the 2016 Commission on Cancer Spring Meeting in Chicago. It was an opportunity to not only network with other cancer doctors from around the United States, but to plan and move forward a number of initiatives that will benefit the eye cancer care community and its patients.

COCSignFinger

Dr. Finger serves as a representative of the American Joint Committee on Cancer (AJCC) to the Commission on Cancer (CoC). He chairs the Ophthalmic Oncology Task Force of the AJCC, which was recently tasked with developing a scientific language that can be used to describe all eye cancers globally. [Learn more about the Eye Cancer Bioinformatics Grid here.]

The CoC is part of the American College of Surgeons, a consortium made up of surgeons and representatives of 56 national professional organizations dedicated to improving survival and quality of life for cancer patients. Dr. Finger has been a Fellow of the American College of Surgeons (F.A.C.S.) for 24 years. The Commission focuses on a number of areas, including standard-setting, prevention, research, education, and monitoring comprehensive quality care. It is responsible for defining and establishing evidence- and consensus-based standards of cancer care and for monitoring compliance with those guidelines.

During the 2-day meeting, Dr. Finger attended lectures and participated in committee work. An example of the learning opportunities at the meeting was a Quintiles Corporation lecture explaining how to link EMR programs from around the world in order to extract clinical data and improve patient care.

The meeting served as an opportunity for Dr. Finger to network with other cancer specialists from around the country.  For example, he was able to spend some time with Dr. Stephen Edge, the former CEO of the AJCC. Dr. Edge was instrumental in helping ophthalmic oncology develop a specific scientific language “staging system” for orbital lymphoma, the most common orbital malignancy.

Dr. Paul Finger (center) poses for a photo with Dr. Stephen Edge (right) and Dr. David Winchester. Dr. Winchester serves as the Medical Director of Cancer Programs at the American College of Surgeons (ACS)
Dr. Paul Finger (center) poses for a photo with Dr. Stephen Edge (right) and Dr. David Winchester. Dr. Winchester serves as the Medical Director of Cancer Programs at the American College of Surgeons (ACS)

The meeting also connected Dr. Finger with up-and-coming cancer physicians through participation in the CoC Mentor Program, in order to pass on knowledge and experience accumulated over his long career. Dr. Finger was paired with Dr. Sangeetha Prabhakaran, Surgical Oncology Research Fellow at the Moffitt Cancer Center in Tampa, Fla.

Dr. Finger pictured with his mentee Dr. Sangeetha Prabhakaran
Dr. Finger pictured with his mentee Dr. Sangeetha Prabhakaran

Dr. Finger’s ongoing work with the Commission on Cancer is part of his commitment to the global fight against eye cancer.

“Medicine is rapidly evolving, so we should always improve. My colleagues are doing groundbreaking work and any chance to cooperate makes us all better physicians. I enjoyed my visit to Chicago very much, and look forward to working even more closely with the CoC to advance eye cancer care.”

The Working Day Initiative

Dr. Finger is helping develop similar projects through the Working Day Initiative that will benefit eye cancer patients worldwide. These include providing eye cancer fellowship grants to bring qualified specialists to unserved countries, developing an open-access surgical text to help generalists currently caring for eye cancer patients, and sharing knowledge among eye cancer specialists. The Working Day Initiative is developing methods to improve quality, by giving the public access to both doctor- and patient-reported outcomes.

Join Our Mailing List

One Response to “Dr. Finger Representing All Eye Cancer Specialists At The Commission On Cancer Spring Meeting 2016”

  1. Rev. Roy Hendrick

    I have read a piece by Dr. Paul Finger about ocular, chorodial 7 day radiation therapy. I had such therapy about 6 years ago and it seems to have been successful. The tumor has not yet returned and of course I hope it never does. Dr. Matt Wilson with Hamilton Clinic in Memphis Tennessee is the surgeon. My reason for writing is a question. Has there been any research on possible radiation side effects affecting the sense of smell some months after the treatment? I have read that this could be a sign of possible dementia but the loss of the sense of smell seemed to have come on within months of the radiation therapy. Dr. Wilson opined that that was probably not the case. I was wondering if your research has ever dealt with this issue. If it is part of onset of dementia I will have to accept that. But the timing of the initial loss of smell seems to be interesting. I’m not complaining – his work here I’m certain saved the eye and probably my life. Just would like to hear back from you sir or one of your people an opinion re this question. Thank you for all your work to help patients like me!
    Rev. H. LeRoy Hendrick Germantown, Tennessee Senior Adult Pastor, Central Church , Collierville, Tennessee. Thank you! 1-901-870-0624

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Patient Stories

"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”
N.N.

Read More

REQUEST AN APPOINTMENT

  • This field is for validation purposes and should be left unchanged.

CONNECT AND SHARE